Germany tries to stop Trump from luring away firm working on coronavirus vaccine

0
289
A biopharmaceutical employee at CureVac demonstrates research for a coronavirus vaccine at a lab in Tuebingen, Germany, on Thursday, March 12, 2020.Andreas Gebert / Reuters

By NBC news

BERLIN — Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine.

German government sources told Reuters on Sunday that the U.S. administration was looking into how it could gain access to a potential vaccine being developed by a German firm, CureVac.

Earlier, the Welt am Sonntag German newspaper reported that U.S. President Donald Trump had offered funds to lure CureVac to the United States, and the German government was making counter-offers to tempt it to stay.

Read full story here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.